Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07173777 · ClinicalTrials.gov registry record · NA
Cardiac Anodal Biphasic Pacing
A NA study, sponsored by Boston Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT07173777 is a NA study that has not yet begun recruiting, run by Boston Medical Center. The registered enrollment target is 108 participants.
The verdict
NCT07173777, a NA study, has not yet begun recruiting, sponsored by Boston Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
The goal of this study is to test a new pacing method called anodal biphasic pacing (ABP) to determine if this pacing works as well-or better-than current pacing methods. This new method may improve how the heart works and reduce some of the problems caused by regular pacing. Current implantable pacemakers use a monophasic cathodal waveform to stimulate the heart. Monophasic cathodal pacing (MCP) waveforms slow conduction, impair contractility, cause inflammation, increase risk of atrial fibrillation, heart failure, and mortality. Anodal biphasic pacing (ABP) is an alternative waveform that can stimulate the heart. ABP preconditions the heart and then initiates cardiac contraction. ABP may address the limitations of MCP.
Interventions
- DEVICE Cardiac Waveform Generator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07173777
The ClinicalTrials.gov registry entry for NCT07173777 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Waveform Generator is the first listed.
NCT07173777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07173777 about?
NCT07173777 is a clinical study titled "Cardiac Anodal Biphasic Pacing". The goal of this study is to test a new pacing method called anodal biphasic pacing (ABP) to determine if this pacing works as well-or better-than current pacing methods. This new method may improve how the heart works and reduce some of the problems caused by regular pacing. Current implantable pa...
What is the current status of trial NCT07173777?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2026-07. Estimated completion is 2027-07.
What interventions are being tested in trial NCT07173777?
The interventions under investigation include: Cardiac Waveform Generator (DEVICE).
Who is sponsoring clinical trial NCT07173777?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.